UBS Maintains Neutral on Gentex, Lowers Price Target to $21
Benzinga Newsdesk 4 days ago
Analyst RatingsNewsPrice Target
UBS analyst Joseph Spak maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $24 to $21.
UBS analyst Joseph Spak maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $24 to $21.